Clinical Trial Update: A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating pre-hospital versus in-hospital initiation of ticagrelor in STEMI patients planned for PCI has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• ticagrelor (Brilinta) (ticagrelor)

Snippet

Sponsor: AstraZeneca | Conditions: Myocardial Infarction, Segment Elevation Myocardial Infarction (STEMI) | Phase 4 | Status: COMPLETED | Results posted: 2015-02-11